Esophagus Cancer Clinical Trials in Hangzhou, Zhejiang
3 recruitingHangzhou, Zhejiang, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
Lung CancerEsophagus Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University120 enrolled1 locationNCT07617246
Recruiting
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
Esophagus Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University120 enrolled2 locationsNCT06385717
Recruiting
Phase 1
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
Breast CancerColorectal, CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd30 enrolled2 locationsNCT06043466